BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16770759)

  • 1. Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland.
    Steffen J; Nowakowska D; Niwińska A; Czapczak D; Kluska A; Piatkowska M; Wiśniewska A; Paszko Z
    Int J Cancer; 2006 Jul; 119(2):472-5. PubMed ID: 16770759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland.
    Steffen J; Varon R; Mosor M; Maneva G; Maurer M; Stumm M; Nowakowska D; Rubach M; Kosakowska E; Ruka W; Nowecki Z; Rutkowski P; Demkow T; Sadowska M; Bidziński M; Gawrychowski K; Sperling K
    Int J Cancer; 2004 Aug; 111(1):67-71. PubMed ID: 15185344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation.
    Steffen J; Maneva G; Popławska L; Varon R; Mioduszewska O; Sperling K
    Int J Cancer; 2006 Dec; 119(12):2970-3. PubMed ID: 16998789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.
    Buslov KG; Iyevleva AG; Chekmariova EV; Suspitsin EN; Togo AV; Kuligina ESh; Sokolenko AP; Matsko DE; Turkevich EA; Lazareva YR; Chagunava OL; Bit-Sava EM; Semiglazov VF; Devilee P; Cornelisse C; Hanson KP; Imyanitov EN
    Int J Cancer; 2005 Apr; 114(4):585-9. PubMed ID: 15578693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
    Kanka C; Brozek I; Skalska B; Siemiatkowska A; Limon J
    Anticancer Res; 2007; 27(4C):3015-8. PubMed ID: 17695489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline 657del5 mutation in the NBS1 gene in breast cancer patients.
    Górski B; Debniak T; Masojć B; Mierzejewski M; Medrek K; Cybulski C; Jakubowska A; Kurzawski G; Chosia M; Scott R; Lubiński J
    Int J Cancer; 2003 Sep; 106(3):379-81. PubMed ID: 12845677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nijmegen Breakage Syndrome mutations and risk of breast cancer.
    Bogdanova N; Feshchenko S; Schürmann P; Waltes R; Wieland B; Hillemanns P; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Varon R; Dörk T
    Int J Cancer; 2008 Feb; 122(4):802-6. PubMed ID: 17957789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
    Roznowski K; Januszkiewicz-Lewandowska D; Mosor M; Pernak M; Litwiniuk M; Nowak J
    Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies.
    Chrzanowska KH; Piekutowska-Abramczuk D; Popowska E; Gładkowska-Dura M; Małdyk J; Syczewska M; Krajewska-Walasek M; Goryluk-Kozakiewicz B; Bubała H; Gadomski A; Gaworczyk A; Kazanowska B; Kołtan A; Kuźmicz M; Luszawska-Kutrzeba T; Maciejka-Kapuścińska L; Stolarska M; Stefańska K; Sznurkowska K; Wakulińska A; Wieczorek M; Szczepański T; Kowalczyk J
    Int J Cancer; 2006 Mar; 118(5):1269-74. PubMed ID: 16152606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risk of heterozygotes with the NBN founder mutation.
    Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
    J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
    Górski B
    Hered Cancer Clin Pract; 2006 Aug; 4(3):142-52. PubMed ID: 20223018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene.
    Ziólkowska I; Mosor M; Wierzbicka M; Rydzanicz M; Pernak-Schwarz M; Nowak J
    Cancer Sci; 2007 Nov; 98(11):1701-5. PubMed ID: 17894553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin.
    Debniak T; Górski B; Cybulski C; Jakubowska A; Kurzawski G; Lener M; Mierzejewski M; Masojć B; Medrek K; Kładny J; Załuga E; Maleszka R; Chosia M; Lubiński J
    Melanoma Res; 2003 Aug; 13(4):365-70. PubMed ID: 12883362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.
    Nowak J; Mosor M; Ziółkowska I; Wierzbicka M; Pernak-Schwarz M; Przyborska M; Roznowski K; Pławski A; Słomski R; Januszkiewicz D
    Eur J Cancer; 2008 Mar; 44(4):627-30. PubMed ID: 18280732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
    Hebbring SJ; Fredriksson H; White KA; Maier C; Ewing C; McDonnell SK; Jacobsen SJ; Cerhan J; Schaid DJ; Ikonen T; Autio V; Tammela TL; Herkommer K; Paiss T; Vogel W; Gielzak M; Sauvageot J; Schleutker J; Cooney KA; Isaacs W; Thibodeau SN
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):935-8. PubMed ID: 16702373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional distribution of heterozygous 657del5 mutation carriers of the NBS1 gene in Wielkopolska province (Poland).
    Ziółkowska I; Mosor M; Nowak J
    J Appl Genet; 2006; 47(3):269-72. PubMed ID: 16877808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic modification of breast cancer risk in women with an NBN mutation.
    Rusak B; Kluźniak W; Wokołorczyk D; Stempa K; Kashyap A; Rudnicka H; Gronwald J; Huzarski T; Dębniak T; Jakubowska A; Szwiec M; Akbari MR; Narod SA; Lubiński J; Cybulski C;
    Breast Cancer Res Treat; 2019 Nov; 178(2):427-431. PubMed ID: 31410679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
    Sokolenko AP; Bogdanova N; Kluzniak W; Preobrazhenskaya EV; Kuligina ES; Iyevleva AG; Aleksakhina SN; Mitiushkina NV; Gorodnova TV; Bessonov AA; Togo AV; Lubiński J; Cybulski C; Jakubowska A; Dörk T; Imyanitov EN
    Breast Cancer Res Treat; 2014 Jun; 145(2):553-62. PubMed ID: 24800916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited NBN Mutations and Prostate Cancer Risk and Survival.
    Rusak B; Kluźniak W; Wokołorczykv D; Stempa K; Kashyap A; Gronwald J; Huzarski T; Dębniak T; Jakubowska A; Masojć B; Akbari MR; Narodv SA; Lubiński J; Cybulski C
    Cancer Res Treat; 2019 Jul; 51(3):1180-1187. PubMed ID: 30590007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer predisposing alleles in Poland.
    Górski B; Cybulski C; Huzarski T; Byrski T; Gronwald J; Jakubowska A; Stawicka M; Gozdecka-Grodecka S; Szwiec M; Urbański K; Mituś J; Marczyk E; Dziuba J; Wandzel P; Surdyka D; Haus O; Janiszewska H; Debniak T; Tołoczko-Grabarek A; Medrek K; Masojć B; Mierzejewski M; Kowalska E; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2005 Jul; 92(1):19-24. PubMed ID: 15980987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.